Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Non-Current Assets (2020 - 2025)

Arcutis Biotherapeutics (ARQT) has 5 years of Non-Current Assets data on record, last reported at -$411.2 million in Q4 2025.

  • For Q4 2025, Non-Current Assets fell 3246.62% year-over-year to -$411.2 million; the TTM value through Dec 2025 reached -$720.4 million, up 18.01%, while the annual FY2025 figure was -$411.2 million, 3246.62% down from the prior year.
  • Non-Current Assets reached -$411.2 million in Q4 2025 per ARQT's latest filing, down from -$349.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $20.4 million in Q1 2025 and bottomed at -$468.1 million in Q1 2024.
  • Average Non-Current Assets over 5 years is -$110.1 million, with a median of $11.4 million recorded in 2023.
  • Peak YoY movement for Non-Current Assets: soared 132.82% in 2022, then plummeted 4072.69% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $5.4 million in 2021, then skyrocketed by 120.64% to $11.9 million in 2022, then dropped by 7.87% to $10.9 million in 2023, then grew by 19.53% to $13.1 million in 2024, then tumbled by 3246.62% to -$411.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were -$411.2 million in Q4 2025, -$349.2 million in Q3 2025, and $19.7 million in Q2 2025.